Use of fibrates to lower cholesterol growing despite mounting evidence they don’t work – By Thomas H. Maugh II – Los Angeles Times (CA) -(Tuesday, March 22, 2011) –

by drsjbecker on March 25, 2011

The use of fibrates and fenofibrates to reduce cholesterol levels has grown sharply in the United States over the past decade, despite mounting evidence that the drugs provide little benefit, researchers reported Tuesday. Moreover, physicians are increasingly prescribing brand-name versions of the drugs, such as TriCor and Trilipix, despite the fact that published evidence so far shows a benefit only for generic forms of the drugs, such as gemfibrozil, researchers reported in the Journal of the American Medical Assn.,0,1959268.story


{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: